Derek R. Johnson, M.D.

Open

• An Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal Dopamine Transporter Visualization Using SPECT Brain Imaging Rochester, Minn.

  The purpose of this study is to determine whether a 5-mCi dose of Altropane is acceptable for visualizing the right and left striata.